Navigation Links
Essilor : 2008 Results
Date:3/5/2009

p>
    The year's highlights included:

    - Solid 4.9% growth in sales of corrective lenses, led by the
      effectiveness of Essilor's networks and the success of new products,
      notably the new generation of Transitions(R) VI variable-tint lenses
      and the new Crizal(R) anti-reflective lenses.

    - Pursuit of the external growth strategy with the acquisition
      of a minority or majority stake in 27 companies, including Satisloh,
      the world leader in optical manufacturing solutions for prescription
      laboratories (see "27 Acquisitions in 2008" below).

    - Continued strong profitability with contribution from
      operations at 17.9% of revenue (18.2% excluding the Satisloh
      acquisition) and attributable net profit at 12.4%.

    - Continued financial solidity. Despite a major investment
      program, gearing remained at less than 5%.

Annual Shareholders' Meeting

The Annual Shareholders' Meeting will be held on Friday, May 15, 2009 at 10:30 a.m. at Palais de la Bourse, Place de la Bourse, 75002 Paris.

The Board of Directors will ask shareholders to approve a dividend of EUR0.66 per share, an increase of 6.5% over the previous year. The dividend will be payable as from May 26, 2009.

Acquisitions in 2009

Pursuing its expansion in Asia-Pacific, Essilor has finalized four acquisitions in Australia representing EUR3.6 million in full-year revenue. Equity interests were acquired in three prescription laboratories-Prescription Glass Pty Ltd, Precision Optics Pty Ltd and Wallace Everett Lens Technology Pty Ltd-and a 50% stake was acquired in Sunix, a developer of optometric practice management systems.

Outlook

In 2009, the global recession has made forecasting growth for the year very uncertain. However the economic crisis does not call into question Essilor's medium- and long-term objectives and the Co
'/>"/>

SOURCE Essilor
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Essilor : 2008 Revenue
2. Essilor Agrees to Acquire Signet Armorlite
3. Essilor Steps Up its Development in Eastern Europe
4. Essilor - First-Half 2008 Revenue
5. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
6. Essilors 2008 First-Quarter Report
7. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
8. Essilor : 2007 Results
9. Essilor Enters Bulgarian Market
10. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
11. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Spring, PA (PRWEB) April 21, 2015 ... Berks County commercial printer, Offset Impressions. , ... its full line of printing capabilities and knowledgeable team ... “This acquisition allows us to offer an ever ... to the labeling, packaging, and specialty services we already ...
(Date:4/21/2015)... The California Healthcare Institute (CHI), ... sciences organizations, released the following statement by CHI ... Assembly Bill (AB) 463: , “As innovators in ... of treatments and cures for patients with serious ... AB 463, the so-called Pharmaceutical Cost Transparency Act ...
(Date:4/21/2015)... 2015 Information is the best weapon in ... FACP, empowers patients and their families with knowledge about living ... and Cancer is the Answer" and new website . ... to guide patients from diagnosis through treatment and even death. ... in their treatment, at home and in the examination room. ...
(Date:4/21/2015)... 21, 2015 The report ... comparative analysis on the therapeutic development for ... by identifying new targets and MOAs to ... with TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... key players involved in the therapeutic development ...
(Date:4/21/2015)... 2015 The 2015 Market Research ... a professional and in-depth study on the current ... with a focus on the Chinese situation. ... citrate market research are Cargill, Fbc Industries, Posy ... Biochemical, Capchem, Lianyungang Mupro Fi, Yixing-Union, Debang Fine ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... LONDON, Nov. 25 Cephalon, Inc.,(Nasdaq: CEPH ... today announced that the companies have signed an Option ... worldwide license to,the investigational medication Lupuzor(TM) for the treatment ... large Phase IIb study of,Lupuzor in patients in Europe ...
... Calif., Nov. 25 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... biopharmaceutical,company developing monoclonal antibodies for the treatment ... that the U.S. Patent and Trademark,Office has ... includes broad,claims covering anti-viral applications of antibodies ...
... ARNA ) announced today that the company is ... Conference on December 3, 2008 at 2:30,p.m. Eastern Time (11:30 ... York City. Jack Lief, Arena,s President and Chief Executive Officer, ... clinical,development and discovery programs. , ...
... a new,commercial finance company that will focus on middle market ... with over $500,million in equity commitments. MidCap,s investors are ... Moelis Capital Partners. MidCap,also has a substantial long-term debt ... Fargo & Company (NYSE: WFC ). , ...
... NEW YORK, Nov. 25 When Professional Basketball player Steve ... Gold Medal Snowboarder Gretchen Bleiler, Gold Medal Swimmer Amanda Beard and ... the slopes or enter an arena, it,s hard to ... , Besides being some of the world,s most accomplished ...
... Inc., a leader in the development and commercialization of ... the AIGISRx(TM) Anti-bacterial Envelope following its commercialization ... anti-bacterial surgical mesh developed to deliver anti-microbial agents that ... and cardioverter defibrillators. , ...
Cached Medicine News:Health News:Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication 2Health News:Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication 3Health News:Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication 4Health News:Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 2Health News:Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 3Health News:Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 4Health News:Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference 2Health News:Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference 3Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 2Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 3Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 4Health News:MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity 5Health News:Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity 2Health News:Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity 3Health News:TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope 2Health News:TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope 3Health News:TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope 4
(Date:4/21/2015)... -- A groundbreaking new, minimally invasive outpatient treatment option ... is now readily available to the estimated 1 million ... who suffer from this condition. ... leading practitioner of this safe, effective, Federal Drug Administration-approved ... new Los Angeles -area medical centers ...
(Date:4/21/2015)... -- Oxfordshire -based ... doubled its overseas sales in just 4 years. ... Queen,s Award for Enterprise, for Outstanding Achievement in International ... Communications consultancy, helping its clients bring new medicines to ... than doubled its exports in just 4 years, from ...
(Date:4/21/2015)... , April 21, 2015 Cardiologists at Henry ... of stroke in patients with an irregular heartbeat. ... procedure, Henry Ford is able to add another ... atrial fibrillation, which affects the heart,s ability to pump. ... and first-ever commercial Watchman implant at a non-clinical ...
Breaking Medicine Technology:New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 2New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 4Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) disclosed today ... (HCV) infected patients with the Aethlon Hemopurifier® will be ... of the American Society of Nephrology (ASN). Dr. Vijay ... of Nephrology at the Fortis Hospital in New Delhi, ...
... LAUSANNE, Switzerland, October 15 Biocartis ... molecular and,immunodiagnostics based on its proprietary micro-technology platform, today,announced ... round. The,Company raised EUR 10 million ( USD 14.9 ... The deal was led by ...
Cached Medicine Technology:Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference 2Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference 3Biocartis Raises EUR10 Million in Series A Financing Round 2Biocartis Raises EUR10 Million in Series A Financing Round 3
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
This large 1000 L tip makes pipetting fragile cells, genomic DNA, and viscous samples easy. Perfect for cell culture laboratories....
300 L, Bulk Recommended for 250 and 300 L pipettes....
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
Medicine Products: